Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-04-24

FDA Approved: LOTEPREDNOL ETABONATE — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' original application for Loteprednol etabonate, a generic ophthalmic corticosteroid for inflammatory eye conditions includin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOTEPREDNOL ETABONATE (Loteprednol etabonate)

Snippet

ORIG AP for LOTEPREDNOL ETABONATE (LOTEPREDNOL ETABONATE)